Radio Hoosh: AI Deep Dives

Anthropic shared early results from using Claude across the drug development pipeline. We look at where the model seems to help, and why many readers doubt how much of the claimed speedup is real and measurable.

Show Notes

AI-generated: both hosts are AI voices (Google NotebookLM), and the conversation is based on the sources listed below.

In this episode we cover Anthropic's new research post on early progress using Claude to speed up drug development. The company describes applying its AI model across the pharma pipeline, from research tasks through the work that leads into clinical development. The post drew wide discussion online, and a lot of it was skeptical: how much of the claimed acceleration is real, and can it be measured?

Drug discovery and development are famously slow and expensive, so even modest real gains would make this one of the most consequential uses of large language models. The details also show where frontier AI models actually help in pharmaceutical work and where they still fall short.

  • What Anthropic reports about using Claude in drug development
  • Which stages of the pipeline the work covers, from early research to the run-up to clinical development
  • Why commenters question whether the speedup is real and measurable
  • Where LLMs seem to add value in pharma, and where they don't
  • What it would take to show that AI really shortens drug development

Sources:

What is Radio Hoosh: AI Deep Dives?

Radio Hoosh takes each day's biggest AI story (a new model, a research paper, a lab announcement or a developer tool) and unpacks it in a 20–45 minute conversation. Both hosts are AI-generated voices (Google NotebookLM), and episodes are produced automatically from public sources such as Hacker News and Hugging Face Daily Papers, then published by Kasra Qasempour. "Hoosh" is Persian for intelligence; a Persian edition is available as رادیو هوش.